Beyond the Wait-and-See: Data-Driven Decision Points for Guiding Selective Serotonin Reuptake Inhibitor Treatment and Cognitive Behavioral Therapy in Pediatric Anxiety Disorders
Journal of Child and Adolescent Psychopharmacology · 01.09.2026 · 36 (7) · 414-422
DOI: 10.1177/10445463261462882 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Child and Adolescent Psychopharmacology, online erschienen am 01.07.2026. Verfasst von Julia N Stimpfl und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Behavioral Neuroscience, College of Medicine, University of Cincinnati, Cincinnati, Ohio, USA. Hauptthemen laut MEDLINE: Anxiety Disorders, Cognitive Behavioral Therapy, Selective Serotonin Reuptake Inhibitors, Sertraline. Die Arbeit nennt 53 Literaturangaben. Gefördert von: National Institute of Child Health & Development, The Yung Family Foundation, American Academy of Child and Adolescent Psychiatry.
Abstract (Originalsprache)
Objectives
To identify early markers of acute treatment response among youth with anxiety disorders receiving cognitive behavioral therapy (CBT), selective serotonin reuptake inhibitor (SSRI) monotherapy, or their combination.
Background
Although many youth with anxiety disorders benefit from CBT or SSRIs, response trajectories vary. Identifying early indicators of nonresponse may guide sequencing strategies and improve timely treatment delivery.
Methods
Using data from the Child/Adolescent Anxiety Multimodal Study, improvement trajectories were modeled for youth (age 7–17) randomized to sertraline monotherapy ( N = 133), CBT monotherapy ( N = 139), their combination ( N = 140), and placebo ( N = 76). Patients were stratified by percent change in Pediatric Anxiety Rating Scale (PARS) scores at multiple time points, and logarithmic and logistic time-trend regression models were used to estimate the probability of response. Receiver operating characteristic (ROC) analyses were used to identify thresholds of improvement for predicting response.
Results
In the sertraline group, ≥25% improvement in PARS score at week 4 had a higher probability of response by week 12 (60.8%) than
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry and Behavioral Neuroscience, College of Medicine, University of Cincinnati, Cincinnati, Ohio, USA.
- Division of Child and Adolescent Psychiatry, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
- Department of Economics, Lindner College of Business, University of Cincinnati, Cincinnati, Ohio, USA.
- University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
- Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
- Prtizker Department of Psychiatry and Behavioral Health, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
ORCID-Profile: Julia N Stimpfl
Förderung
- National Institute of Child Health & Development
- The Yung Family Foundation
- American Academy of Child and Adolescent Psychiatry
Zitieren
APA
Stimpfl, J. N., Mills, J. A., Dahlsgaard, K. K., Peris, T. S., Piacentini, J. C., Walkup, J. T., & Strawn, J. R. (2026). Beyond the Wait-and-See: Data-Driven Decision Points for Guiding Selective Serotonin Reuptake Inhibitor Treatment and Cognitive Behavioral Therapy in Pediatric Anxiety Disorders. Journal of Child and Adolescent Psychopharmacology, 36(7), 414-422. https://doi.org/10.1177/10445463261462882
Vancouver
Stimpfl JN, Mills JA, Dahlsgaard KK, Peris TS, Piacentini JC, Walkup JT, et al. Beyond the Wait-and-See: Data-Driven Decision Points for Guiding Selective Serotonin Reuptake Inhibitor Treatment and Cognitive Behavioral Therapy in Pediatric Anxiety Disorders. Journal of Child and Adolescent Psychopharmacology. 2026;36(7):414-422. doi:10.1177/10445463261462882
BibTeX
@article{Stimpfl2026,
author = {Stimpfl, Julia N and Mills, Jeffrey A and Dahlsgaard, Katherine K and Peris, Tara S and Piacentini, John C and Walkup, John T and Strawn, Jeffrey R},
title = {Beyond the Wait-and-See: Data-Driven Decision Points for Guiding Selective Serotonin Reuptake Inhibitor Treatment and Cognitive Behavioral Therapy in Pediatric Anxiety Disorders},
journal = {Journal of Child and Adolescent Psychopharmacology},
year = {2026},
volume = {36},
number = {7},
pages = {414--422},
doi = {10.1177/10445463261462882}
}
EUVIMED